Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyphal wall protein 1 (HWP1) is a major cell surface adhesin and critical virulence factor uniquely expressed during the hyphal (filamentous) phase of the opportunistic pathogen Candida albicans [1, 5, 7]. It functions as a specialized substrate for mammalian transglutaminases, enabling the fungus to form covalent isopeptide bonds with host epithelial cells, effectively 'tethering' the pathogen to host tissues with the same strength as native host protein interactions [2, 4, 12]. This covalent attachment is essential for the establishment of mucosal infections, such as oral and esophageal candidiasis, and is a key driver in the formation and structural integrity of fungal biofilms on both biological surfaces and medical devices like catheters [2, 3, 9]. Due to its surface accessibility and vital role in pathogenesis, HWP1 is a primary target for the development of novel antifungal vaccines, therapeutic antibodies, and diagnostic markers for invasive candidiasis [1, 8, 13]. While HWP1 is highly specific to the hyphal form, its sequence shares partial homology with gluten-derived gliadin, leading to hypotheses regarding its potential role in triggering or exacerbating Celiac disease through molecular mimicry [5, 15]. Therapeutic strategies targeting HWP1 aim to disrupt the fungal-host interface and prevent the biofilm-mediated resistance and dissemination characteristic of chronic and systemic Candida infections [2, 9, 14].
Inhibition of fungal adhesion to host tissues, disruption of biofilm structural integrity, and induction of protective humoral and cellular immunity through vaccination.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyphal wall protein 1 (HWP1) (HWP1).